ポナチニブの世界市場2020-2026:45mg、15mg

QYResearchが発行した調査報告書(QYR20AP01885)
◆英語タイトル:Global Ponatinib Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01885
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ポナチニブの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ポナチニブのグローバル市場動向、メーカー別競争状況、種類別市場規模(45mg、15mg)、用途別市場規模(CML、ALL)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ポナチニブの種類別市場2015-2026:45mg、15mg
・ポナチニブの用途別市場2015-2026:CML、ALL
・ポナチニブの北米市場分析
・ポナチニブのアジア市場分析
・ポナチニブの中南米市場分析
・ポナチニブの中東・アフリカ市場分析
・関連企業情報:ARIAD Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).In 2019, the global Ponatinib market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Ponatinib.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Ponatinib market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Ponatinib market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Ponatinib market. Readers of the report can become informed about current and future trends of the global Ponatinib market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Ponatinib markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Ponatinib market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Ponatinib market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Ponatinib market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Ponatinib market is segmented into
45mg
15mg

Market Segment by Application, the Ponatinib market is segmented into
CML
ALL

This report includes the following manufacturers; we can also add the other companies as you want.
ARIAD Pharmaceuticals

The study objectives are:
To analyze and research the global Ponatinib status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Ponatinib manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ponatinib are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Ponatinib Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Ponatinib Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 45mg
1.3.3 15mg
1.4 Market Segment by Application
1.4.1 Global Ponatinib Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 CML
1.4.3 ALL
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Ponatinib Revenue (2015-2026)
2.1.1 Global Ponatinib Revenue (2015-2026)
2.1.2 Global Ponatinib Sales (2015-2026)
2.2 Ponatinib Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Ponatinib Sales by Regions (2015-2020)
2.2.2 Global Ponatinib Revenue by Regions (2015-2020)
2.3 Global Top Ponatinib Regions (Countries) Ranking by Market Size
2.4 Ponatinib Industry Trends
2.4.1 Ponatinib Market Top Trends
2.4.2 Market Drivers
2.4.3 Ponatinib Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Ponatinib Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Ponatinib Manufacturers by Sales (2015-2020)
3.1.1 Global Ponatinib Sales by Manufacturers (2015-2020)
3.1.2 Global Ponatinib Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Ponatinib Sales in 2019
3.2 Global Top Manufacturers Ponatinib by Revenue
3.2.1 Global Ponatinib Revenue by Manufacturers (2015-2020)
3.2.2 Global Ponatinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ponatinib Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ponatinib as of 2019)
3.4 Global Ponatinib Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Ponatinib Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Ponatinib Market
3.7 Key Manufacturers Ponatinib Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Ponatinib Historic Market Review by Type (2015-2020)
4.1.2 Global Ponatinib Sales Market Share by Type (2015-2020)
4.1.3 Global Ponatinib Revenue Market Share by Type (2015-2020)
4.1.4 Ponatinib Price by Type (2015-2020)
4.1 Global Ponatinib Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Ponatinib Sales Forecast by Type (2021-2026)
4.2.3 Global Ponatinib Revenue Forecast by Type (2021-2026)
4.2.4 Ponatinib Price Forecast by Type (2021-2026)

5 Global Ponatinib Market Size by Application
5.1 Global Ponatinib Historic Market Review by Application (2015-2020)
5.1.2 Global Ponatinib Sales Market Share by Application (2015-2020)
5.1.3 Global Ponatinib Revenue Market Share by Application (2015-2020)
5.1.4 Ponatinib Price by Application (2015-2020)
5.2 Global Ponatinib Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Ponatinib Sales Forecast by Application (2021-2026)
5.2.3 Global Ponatinib Revenue Forecast by Application (2021-2026)
5.2.4 Ponatinib Price Forecast by Application (2021-2026)

6 North America
6.1 North America Ponatinib Breakdown Data by Company
6.2 North America Ponatinib Breakdown Data by Type
6.3 North America Ponatinib Breakdown Data by Application
6.4 North America Ponatinib Breakdown Data by Countries
6.4.1 North America Ponatinib Sales by Countries
6.4.2 North America Ponatinib Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Ponatinib Breakdown Data by Company
7.2 Europe Ponatinib Breakdown Data by Type
7.3 Europe Ponatinib Breakdown Data by Application
7.4 Europe Ponatinib Breakdown Data by Countries
7.4.1 Europe Ponatinib Sales by Countries
7.4.2 Europe Ponatinib Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Ponatinib Breakdown Data by Company
8.2 Asia Pacific Ponatinib Breakdown Data by Type
8.3 Asia Pacific Ponatinib Breakdown Data by Application
8.4 Asia Pacific Ponatinib Breakdown Data by Regions
8.4.1 Asia Pacific Ponatinib Sales by Regions
8.4.2 Asia Pacific Ponatinib Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Ponatinib Breakdown Data by Company
9.2 Latin America Ponatinib Breakdown Data by Type
9.3 Latin America Ponatinib Breakdown Data by Application
9.4 Latin America Ponatinib Breakdown Data by Countries
9.4.1 Latin America Ponatinib Sales by Countries
9.4.2 Latin America Ponatinib Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Ponatinib Breakdown Data by Type
10.2 Middle East and Africa Ponatinib Breakdown Data by Application
10.3 Middle East and Africa Ponatinib Breakdown Data by Countries
10.3.1 Middle East and Africa Ponatinib Sales by Countries
10.3.2 Middle East and Africa Ponatinib Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Corporation Information
11.1.2 ARIAD Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 ARIAD Pharmaceuticals Ponatinib Products and Services
11.1.5 ARIAD Pharmaceuticals SWOT Analysis
11.1.6 ARIAD Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ponatinib Sales Channels
12.2.2 Ponatinib Distributors
12.3 Ponatinib Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Ponatinib Sales Forecast (2021-2026)
13.1.1 Global Ponatinib Sales Forecast by Regions (2021-2026)
13.1.2 Global Ponatinib Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Ponatinib Sales Forecast (2021-2026)
13.2.2 North America Ponatinib Revenue Forecast (2021-2026)
13.2.3 North America Ponatinib Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Ponatinib Sales Forecast (2021-2026)
13.3.2 Europe Ponatinib Revenue Forecast (2021-2026)
13.3.3 Europe Ponatinib Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Ponatinib Sales Forecast (2021-2026)
13.4.2 Asia Pacific Ponatinib Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Ponatinib Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Ponatinib Sales Forecast (2021-2026)
13.5.2 Latin America Ponatinib Revenue Forecast (2021-2026)
13.5.3 Latin America Ponatinib Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Ponatinib Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Ponatinib Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Ponatinib Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Ponatinib Key Market Segments
Table 2. Ranking of Global Top Ponatinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ponatinib Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of 45mg
Table 5. Major Manufacturers of 15mg
Table 6. Global Ponatinib Market Share by Application 2019-2025 (K Units)
Table 7. Global Ponatinib Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Ponatinib Sales by Regions 2015-2020 (K Units)
Table 9. Global Ponatinib Sales Market Share by Regions 2015-2020
Table 10. Global Ponatinib Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Ponatinib Revenue Market Share by Regions 2015-2020
Table 12. Top Ponatinib Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Ponatinib Key Drivers: Impact Analysis (2021-2026)
Table 15. Ponatinib Key Challenges
Table 16. Main Points Interviewed from Key Ponatinib Players: Views for Future
Table 17. Global Ponatinib Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Ponatinib Sales Share by Manufacturers (2015-2020)
Table 19. Ponatinib Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Ponatinib Revenue Share by Manufacturers (2015-2020)
Table 21. Global Ponatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ponatinib as of 2019)
Table 23. Key Manufacturers Ponatinib Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Ponatinib Plants/Factories Distribution
Table 25. Key Manufacturers Ponatinib Area Served
Table 26. Date of Key Manufacturers Enter into Ponatinib Market
Table 27. Key Manufacturers Ponatinib Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 45mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global 15mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Ponatinib Sales (K Units) by Type (2015-2020)
Table 32. Global Ponatinib Sales Share by Type (2015-2020)
Table 33. Global Ponatinib Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Ponatinib Price (K Units) by Type (2015-2020)
Table 35. Global Ponatinib Sales (K Units) by Type (2021-2026)
Table 36. Global Ponatinib Sales Share by Type (2021-2026)
Table 37. Global Ponatinib Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Ponatinib Revenue Share by Type (2021-2026)
Table 39. Global Ponatinib Price (K Units) by Type (2021-2026)
Table 40. Global Ponatinib Sales (K Units) by Application (2015-2020)
Table 41. Global Ponatinib Sales Share by Application (2015-2020)
Table 42. Global Ponatinib Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Ponatinib Price by Application 2015-2020 (USD/Unit)
Table 44. Global Ponatinib Sales by Application (2015-2020) (K Units)
Table 45. Global Ponatinib Sales Share by Application (2015-2020)
Table 46. Global Ponatinib Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Ponatinib Revenue Share by Application (2021-2026)
Table 48. Global Ponatinib Price (K Units) by Application (2021-2026)
Table 49. North America Ponatinib Sales by Company (2015-2020) (K Units)
Table 50. North America Ponatinib Sales Market Share by Company (2015-2020)
Table 51. North America Ponatinib Sales by Type (2015-2020) (K Units)
Table 52. North America Ponatinib Sales Market Share by Type (2015-2020)
Table 53. North America Ponatinib Sales by Application (2015-2020) (K Units)
Table 54. North America Ponatinib Sales Market Share by Application (2015-2020)
Table 55. North America Ponatinib Sales by Countries (2015-2020) (K Units)
Table 56. North America Ponatinib Sales Market Share by Countries (2015-2020)
Table 57. North America Ponatinib Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Ponatinib Revenue Market Share by Countries (2015-2020)
Table 59. Europe Ponatinib Sales by Company (2015-2020) (K Units)
Table 60. Europe Ponatinib Sales Market Share by Company (2015-2020)
Table 61. Europe Ponatinib Sales by Type (2015-2020) (K Units)
Table 62. Europe Ponatinib Sales Market Share by Type (2015-2020)
Table 63. Europe Ponatinib Sales by Application (2015-2020) (K Units)
Table 64. Europe Ponatinib Sales Market Share by Application (2015-2020)
Table 65. Europe Ponatinib Sales by Countries (2015-2020) (K Units)
Table 66. Europe Ponatinib Sales Market Share by Countries (2015-2020)
Table 67. Europe Ponatinib Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Ponatinib Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Ponatinib Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Ponatinib Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Ponatinib Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Ponatinib Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Ponatinib Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Ponatinib Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Ponatinib Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Ponatinib Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Ponatinib Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Ponatinib Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Ponatinib Sales by Company (2015-2020) (K Units)
Table 80. Latin America Ponatinib Sales Market Share by Company (2015-2020)
Table 81. Latin America Ponatinib Sales by Type (2015-2020) (K Units)
Table 82. Latin America Ponatinib Sales Market Share by Type (2015-2020)
Table 83. Latin America Ponatinib Sales by Application (2015-2020) (K Units)
Table 84. Latin America Ponatinib Sales Market Share by Application (2015-2020)
Table 85. Latin America Ponatinib Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Ponatinib Sales Market Share by Countries (2015-2020)
Table 87. Latin America Ponatinib Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Ponatinib Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Ponatinib Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Ponatinib Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Ponatinib Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Ponatinib Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Ponatinib Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Ponatinib Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Ponatinib Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Ponatinib Revenue Market Share by Countries (2015-2020)
Table 97. ARIAD Pharmaceuticals Company Details
Table 98. ARIAD Pharmaceuticals Description and Business Overview
Table 99. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. ARIAD Pharmaceuticals Ponatinib Sales Growth Rate (2015-2020)
Table 101. ARIAD Pharmaceuticals Ponatinib Sales Market Share in Global Market
Table 102. ARIAD Pharmaceuticals Recent Development
Table 103. Ponatinib Distributors List
Table 104. Ponatinib Customers List
Table 105. Global Ponatinib Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Ponatinib Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Ponatinib Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Ponatinib Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Ponatinib Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Ponatinib Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Ponatinib Revenue Forecast by Countries 2021-2026
Table 112. Europe Ponatinib Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Ponatinib Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Ponatinib Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Ponatinib Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Ponatinib Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Ponatinib Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Ponatinib Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Ponatinib Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Ponatinib Product Picture
Figure 2. Global Ponatinib Sales Market Shar by Type 2015-2026
Figure 3. 45mg Figures
Figure 4. 15mg Figures
Figure 5. Global Ponatinib Sales Market Share by Application in 2019 & 2026
Figure 6. CML Use Case
Figure 7. ALL Use Case
Figure 8. Ponatinib Report Years Considered
Figure 9. Global Ponatinib Market Size 2015-2026 (Million US$)
Figure 10. Global Ponatinib Sales 2015-2020 (K Units)
Figure 11. Global Ponatinib Market Size Market Share by Regions 2015-2020
Figure 12. Global Ponatinib Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Ponatinib Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Ponatinib Sales in 2019
Figure 16. Ponatinib Value Share by Manufacturers in 2019
Figure 17. Ponatinib Revenue Share by Manufacturers In 2019
Figure 18. Ponatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Ponatinib Revenue Share by Type (2015-2020)
Figure 20. Global Ponatinib Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Ponatinib Market Share by Price Range (2015-2020)
Figure 22. Global Ponatinib Revenue Share by Application (2015-2020)
Figure 23. Global Ponatinib Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Ponatinib Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Ponatinib Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Ponatinib Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Ponatinib Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Ponatinib Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Ponatinib Sales Growth Rate (2015-2020) (K Units)
Figure 53. ARIAD Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ponatinib Value Chain
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. North America Ponatinib Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 58. North America Ponatinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 59. Europe Ponatinib Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 60. Europe Ponatinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Asia Pacific Ponatinib Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 62. Asia Pacific Ponatinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Latin America Ponatinib Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. Latin America Ponatinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Middle East and Africa Ponatinib Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Middle East and Africa Ponatinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


【掲載企業】

ARIAD Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ポナチニブの世界市場2020-2026:45mg、15mg(Global Ponatinib Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。